Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992.
The early 2000s, the company established offices in the United States and Russia, then signed an agreement to produce oral cephalosporin for the U.S. market in the mid-2000s.
In 2008 and 2009, the company received approval to enter the Canadian and Australian markets and established a wholly owned subsidiary in Japan.
Orchid's main products are active pharmaceutical ingredients, including cephalosporins (oral and injectable), carbapenems and penicillin.
Orchid Pharma securities are traded at NSE, BSE, MSE, and Singapore Stock Exchange.